The value of cytoreductive nephrectomy on the survival of metastatic renal carcinoma patients based on the number of site-specific metastases.
Zhijian ZhaoWenqi WuXiaolu DuanGuohua ZengYongda LiuPublished in: PloS one (2019)
The potential benefit of CN disappeared in patients with ≥ 3 site-specific metastases, or patients with ≥cT3 combined with ≥ 2 site-specific metastases.
Keyphrases
- end stage renal disease
- newly diagnosed
- squamous cell carcinoma
- ejection fraction
- small cell lung cancer
- chronic kidney disease
- computed tomography
- prognostic factors
- peritoneal dialysis
- lymph node metastasis
- risk assessment
- image quality
- magnetic resonance
- positron emission tomography
- climate change
- minimally invasive